The DOI matches its Crossref record.
Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
Abstract
Obesity is commonly associated with elevated plasma free fatty acid (FFA) levels, as well as with insulin resistance and hyperinsulinemia, two important cardiovascular risk factors. What causes insulin resistance and hyperinsulinemia in obesity remains uncertain. Here, we have tested the hypothesis that FFAs are the link between obesity and insulin resistance/hyperinsulinemia and that, therefore, lowering of chronically elevated plasma FFA levels would improve insulin resistance/hyperinsulinemia and glucose tolerance in obese nondiabetic and diabetic subjects. Acipimox (250 mg), a long-acting antilipolytic drug, or placebo was given overnight (at 7:00 P.M., 1:00 A.M., 7:00 A.M.) to 9 lean control subjects, 13 obese nondiabetic subjects, 10 obese subjects with impaired glucose tolerance, and 11 patients with type 2 diabetes. Euglycemic-hyperinsulinemic clamps and oral glucose tolerance tests (75 g) were performed on separate mornings after overnight Acipimox or placebo treatment. In the three obese study groups, Acipimox lowered fasting levels of plasma FFAs (by 60-70%) and plasma insulin (by approximately 50%). Insulin-stimulated glucose uptake during euglycemic-hyperinsulinemic clamping was more than twofold higher after Acipimox than after placebo. Areas under the glucose and insulin curves during oral glucose tolerance testing were both approximately 30% lower after Acipimox administration than after placebo. We conclude that lowering of elevated plasma FFA levels can reduce insulin resistance/hyperinsulinemia and improve oral glucose tolerance in lean and obese nondiabetic subjects and in obese patients with type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, reduction of plasma FFA concentration in insulin resistant individuals, for example, type 2 diabetic subjects, augments insulin-stimulated glucose disposal in skeletal muscle [69–72], and the improvement in insulin sensitivity is closely associated with a reduction in intramyocellular FACoA concentration [69].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [72]
In the citing paper
“Further evidence linking fatty acids to insulin sensitivity comes from clinical studies showing that pharmacological inhibition of lipolysis decreases fatty acid levels and rapidly enhances insulin sen-sitivity in diabetic and nondiabetic, lean and obese subjects (48,49).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [48]
Citations
Cited by
Sorted by citations
Items 301–400 of 431
Defective Visceral Adipose Tissue Adaptation in Gestational Diabetes Mellitus
McElwain, C. J., Manna, S., Musumeci, A., Sylvester, I., Rouchon, C., O'Callaghan, A. M., Ebad, M. A. B., McCarthy, F. P., & McCarthy, C. M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad699 · Cited by 7
High-Affinity Niacin Receptor GPR109A Agonists
Shen, H. C., & Colletti, S. L. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45005-8 · Cited by 7
Insulin Resistance and Inflammation
Boden, G. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00008-9 · Cited by 7
Self-citationStorz, M. A., & Küster, O. (2019) · Nutrition and Health · doi:10.1177/0260106019874683 · Cited by 7
“On the other hand, Santomauro et al. (1999) demonstrated that lowering of elevated plasma free fatty acid levels can reduce insulin resistance and hyperinsulinemia in obese patients with type 2 diabetes within a few hours.”
BackgroundLove, K. M., Jahn, L. A., Hartline, L. M., Aylor, K. W., & Liu, Z. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad656 · Cited by 7
The role of the lipotoxicity in the pathogenesis of type 2 diabetes mellitus and obesity
Абдулкадирова, Ф. Р., As, A., Doskina, E. V., & Покровская, Р. А. (2014) · Obesity and metabolism · doi:10.14341/omet201428-12 · Cited by 7
WAJCHENBERG, B. L., Amâncio, R. F., Santomauro, A. T. M. G., & Maranhão, R. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02103.x · Cited by 7
Self-citationLa cintura hipertrigliceridémica
Ascaso, J. F. (2005) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(05)73357-x · Cited by 8
Giggins, O. M., Crowe, L., Coughlan, G. F., & Caulfield, B. (2017) · British Journal of Diabetes · doi:10.15277/bjd.2017.127 · Cited by 7
Johnson, N. A., Stannard, S. R., ROWLANDS, D. S., Chapman, P., Thompson, C. H., Sachinwalla, T., & Thompson, M. W. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01952.x · Cited by 7
Varma, S., & Khandelwal, R. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21525 · Cited by 7
“, are known to contribute to insulin resistance in various types of cells [Hotamisligil et al., 1993; Roden et al., 1996; Santomauro et al., 1999; Gual et al., 2005].”
BackgroundMcCarty, M. F. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1454 · Cited by 7
Short-term mild hyperglycemia enhances insulin-stimulated glucose disposal in lactating goats
Lemosquet, S., Debras, E., Balage, M., Hocquette, J.-F. J.-F., Rulquin, H., & Grizard, J. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2002.282.2.r464 · Cited by 7
“It is well established that a decrease in FFA stimulates glucose uptake during euglycemic hyperinsulinemic clamps (48).”
BackgroundCardiovascular Effects of Thiazolidinediones
Suwattee, P., Desouza, C. V., Asnani, S., Gilling, L., & Fonseca, V. A. (2002) · The Endocrinologist · doi:10.1097/00019616-200203000-00011 · Cited by 7
Short‐term acipimox treatment is associated with decreased cardiac parasympathetic modulation
Vestergaard, E. T., Cichosz, S. L., Møller, N., Jørgensen, J. O. L., & Fleischer, J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13384 · Cited by 6
Diabetes Mellitus and Cardiovascular Disease in the Elderly
Gregoratos, G., & Leung, G. (2008) · Fundamental and clinical cardiology · doi:10.3109/9781420061710.007 · Cited by 6
Almquist, J. O., Hovdal, D., Ahlström, C., Fjellström, O., Gennemark, P., & Sundqvist, M. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.022 · Cited by 6
“…of lipolysis in the adipocytes by nicotinic acid or its analogues acutely improves glucose handling and insulin sensitivity in subjects with T2DM (Bajaj et al., 2004; Dobbins et al., 2013; Fulcher et al., 1992; Kumar et al., 1994; Liang et al., 2013; Santomauro et al., 1999; Worm et al., 1994).”
BackgroundInfluentialCao, Y., Xu, R., & Zhang, J. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1679527 · Cited by 5
The benefits of hypoglycemic therapy for patients with obstructive sleep apnea
Lin, R., Yan, W., He, M., Liu, B., Su, X., Yi, M., & Zhang, Y. (2024) · Sleep And Breathing · doi:10.1007/s11325-024-03015-2 · Cited by 5
Komiyama, N., Saito, T., Hosaka, Y., Aida, K., Kaneko, T., Sato, A., Onaya, T., Kobayashi, T., & Tawata, M. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.10.002 · Cited by 5
Iatrogenic lipodystrophy in HIV patients – the need for very-low-fat diets
McCarty, M. F. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00230-5 · Cited by 4
Pothireddy, S., Chukka, S., & Puligilla, S. (2014) · International Journal of Research and Development in Pharmacy and Life Sciences · Cited by 5
Grošelj, U., Kafol, J., Šikonja, J., Mlinarič, M., Šket, R., Remec, Ž. I., Kovač, J., Torkar, A. D., Omladič, J. Š., Lampret, B. R., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101016 · Cited by 4
Dirks, M. L., Jameson, T. S. O., Andrews, R. C., Dunlop, M. V., Abdelrahman, D. R., Murton, A. J., Wall, B. T., & Stephens, F. B. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00345.2023 · Cited by 4
Deane, C. S., Willis, C. R. G., Gallagher, I. J., Brook, M. S., Gharahdaghi, N., Wylie, L. J., Wilkinson, D. J., Smith, K. E., Atherton, P. J., & Etheridge, T. (2024) · Translational Exercise Biomedicine · doi:10.1515/teb-2024-0030 · Cited by 4
“The NA slow release donor (acipimox) also improves insulin sensitivity [34] and increases mitochondrial respiration in type II diabetics [35, 36].”
Fat Metabolism in Insulin Resistance and Type 2 Diabetes
Duez, H., & Lewis, G. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_4 · Cited by 4
Vascular biomarkers in the metabolic syndrome
Thande, N. K., & Rosenson, R. S. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.2 · Cited by 4
Obesity and Glucose Metabolism
Napoli, N., & Pozzilli, P. (2014) · Springer eBooks · doi:10.1007/978-3-319-09045-0_11 · Cited by 4
Mechanism of Lipid Induced Insulin Resistance: An Overview
Bhattacharya, S., Kundu, R., Dasgupta, S., & Bhattacharya, S. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.1.12 · Cited by 5
“There may be others, but reports on circulatory lipid profile in diabetic patients showed prevalence of these FAs and research area in the field of insulin resistance has predominantly used these FAs to blunt insulin sensitivity [6,12,13].”
BackgroundEffects of thiazolidinediones on cardiovascular risk factors
Gouda, B. P., Asnani, S., & Fonseca, V. A. (2002) · Comprehensive Therapy · doi:10.1007/s12019-002-0018-8 · Cited by 4
Mechanisms and Complications of Metabolic Syndrome
Wang, M. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch7 · Cited by 4
Obesity and Disease: Insulin Resistance, Diabetes, Metabolic Syndrome and Polycystic Ovary Syndrome
Proietto, J. (2005) · Wiley eBooks · doi:10.1002/9780470987087.ch13 · Cited by 4
Marcus, A. (2001) · The Endocrinologist · doi:10.1097/00019616-200109000-00005 · Cited by 4
Henderson, G. C. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.07.019 · Cited by 3
PATHOPHYSIOLOGY OF DIABETES MELLITUS AND ITS RELATIONSHIP WITH OBESITY IN CATS
Rotlewicz, N. B., Gallelli, M. F., Blatter, M. F. C., Miceli, D. D., & Castillo, V. A. (2010) · Slovenian Veterinary Research · Cited by 3
Omolekulo, T. E., Areola, E. D., Badmus, O. O., Michael, O. S., Kim, I., & Olatunji, L. A. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0231 · Cited by 3
Interaction between Lipid Availability, Endurance Exercise and Insulin Sensitivity
Newsom, S. A., & Schenk, S. (2014) · Medicine and sport science/Medicine and sport · doi:10.1159/000357336 · Cited by 3
Are we waking up to the effects of NEFA?
Jun, J. C., & Polotsky, V. Y. (2015) · Diabetologia · doi:10.1007/s00125-014-3489-0 · Cited by 3
“Conversely, acutely lowering plasma NEFA with acipimox improved insulin sensitivity within 12 h [21].”
BackgroundPPARγ Agonists and Vascular Risk Factors: Potential Effects on Cardiovascular Disease
Asnani, S., Theuma, P., & Fonseca, V. A. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903321648234 · Cited by 3
Musi, N., & Bartke, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_12 · Cited by 5
Niacin, Metabolic Stress and Insulin Resistance in Dairy Cows
Cincović, M., Hristovska, T., & Belić, B. (2018) · InTech eBooks · doi:10.5772/intechopen.77268 · Cited by 3
“Acipimox was shown to decrease blood NEFA concentrations, increase the response to the oral glucose tolerance test and enhance the insulin-stimulated glucose uptake in peripheral tissue (using the hyperinsulinemic-euglycemic clamp technique) [53, 54].”
MethodInsulin Resistance Alzheimer's Disease: Pathophysiology and Treatment
Watson, G. S., & Craft, S. (2007) · Progress in Neurotherapeutics and Neuropsychopharmacology · doi:10.1017/s1748232107000031 · Cited by 3
Obesity and Diabetes Mellitus 2: Interrelated Relative Relationship
Albajy, M. A., & Mihailescu, D. F. (2023) · International Journal of Research and Review · doi:10.52403/ijrr.20230933 · Cited by 2
Banerjee, S., Maity, S., Ghosh, S., Gautam, A., Chakraborty, I., & Manik, N. B. (2026) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2026.107092 · Cited by 2
Monoacylglycerol as a Metabolic Coupling Factor in Glucose-Stimulated Insulin Secretion
Zhao, S., Iglesias, J., Mugabo, Y., Peyot, M., Joly, E. C., Madiraju, S. R. M., & Prentki, M. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.019 · Cited by 2
“Decreasing the FFA level in obese nondiabetic individuals is helpful to ameliorate insulin sensitivity in skeletal muscle (Santomauro et al., 1999).”
BackgroundKİSMİROĞLU, C., & Yaman, M. (2020) · European Journal of Science and Technology · doi:10.31590/ejosat.746132 · Cited by 2
Yan, F., Tian, L., Xiao, Z., Li, S., Fu, M., & Tian, H. (2014) · Clinical Lipidology · doi:10.2217/clp.14.11 · Cited by 2
Effect of Fatty Acids and Antioxidants on Glucose Tolerance
Stancioiu, F. (2007) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2007.391 · Cited by 2
Adipocyte Dysfunction, Inflammation, and Insulin Resistance in Obesity
Jahansouz, C. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3220-7_5 · Cited by 2
Significance of Organ Crosstalk in Insulin Resistance and Type 2 Diabetes
Bhatt, S., & Kulkarni, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00017-8 · Cited by 2
Cuker, B. E. (2020) · Estuaries of the world · doi:10.1007/978-3-030-45481-4_13 · Cited by 2
The relationship between obesity and type 2 diabetes—the role of gut factors
Hsia, D. S., & Cefalu, W. T. (2015) · doi:10.1002/9781118387658.ch31 · Cited by 2
Role of methylglyoxal in the pathogenesis of insulin resistance
Jia, X. (2010) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 2
Li, H., Wang, Y., Ran, M., Gao, F., Zhu, B.-Y., Xiao, H.-Y., & Xu, C. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i2.97910 · Cited by 1
Fat-Induced Insulin Resistance and Atherosclerosis
Boden, G. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_49 · Cited by 1
Self-citationFree Fatty Acids, Insulin Resistance, and Ectopic Fat
Kelley, D. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_5 · Cited by 1
“Clinical investigations have revealed that overnight lowering of FFA in patients with type 2 diabetes improves IR ( 12 ).”
BackgroundThe Role of Insulin Resistance in Age-Related Cognitive Decline and Dementia
Watson, G. S., & Craft, S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_18 · Cited by 1
“Elevated FFAs are common in people with obesity or insulin resistance, and normalization of FFA levels typically leads to a dramatic improvement in insulin sensitivity ( 74 ).”
BackgroundNonalcoholic Fatty Liver (NAFL): Overview
Caldwell, S. H., Al‐Osaimi, A. M. S., Chang, C., Davis, C. A., Hespenheide, E. E., Krugner-Higby, L. A., Hylton, A. I., Iezzoni, J. C., Le, T. H., Nakamoto, R. K., et al. (2005) · doi:10.1007/4-431-27172-4_1 · Cited by 1
“Other candidate agents include acarbose [an a-glucosidase inhibitor) [349], acipimox (inhibits lipolysis) [350], and dchiro-inositol [351].”
BackgroundDasgupta, S., Borgohain, T., Gogoi, B., & Buragohain, A. K. (2014) · American journal of phytomedicine and clinical therapeutics · Cited by 1
Weigert, A., Klopfer, K., Kausch, C., Brodbeck, K., Stümvoll, M., & Schleicher, E. D. (2003) · Cited by 1
Bowden, D. W., Wing, M. R., Hicks, A. A., Allred, N., Talbert, J., Knauss, S., & Idol, B. (2009) · Cited by 1
Guo, C. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2vw2m · Cited by 1
“glucose uptake and glucose tolerance improve with an acute decrease in NEFA levels after treatment with acipimox, a nicotinic acid analogue and a potent inhibitor of adipose tissue lipolysis ([38]).”
BackgroundYang, J. (2009) · Cited by 1
The effects of high intensity interval training on indices of glucose handling in type 2 diabetics
Shaban, N. (2011) · Cited by 1
Making lifestyle work : long-term effects in the prevention of type 2 diabetes
Roumen, C. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091106cr · Cited by 1
Peptídeos intracelulares na obesidade e resistência à insulina
Berti, D. A. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2010.tde-19052010-131337 · Cited by 1
Atherosclerosis II : HDL Elevation
Ali, A., Hunt, J. A., & Sinclair, P. J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc193 · Cited by 1
Fragasso, G., Palloshi, A., & Perseghin, G. (2007) · Circulation · doi:10.1161/circulationaha.106.679472 · Cited by 1
Linde, R. B., & Linde, B. (2001) · Cardiology in Review · doi:10.1097/00045415-200111000-00011 · Cited by 2
“One investigation found that a long-acting antilipolytic niacin analog lowered circulating fatty acids and improved insulin action (48).”
BackgroundDavis, J. E. (2008) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-1101 · Cited by 1
Connell, N. J. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210122nc · Cited by 1
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Obesity-associated inflammation in adipose tissue
Alvehus, M. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
REGULATION OF ATP BINDING CASSETTE TRAN SPORTER A1 AND G1 EXPRESSION BY
Ku, C. S. (2010) · Lincoln (University of Nebraska)
Hagan, G. N. (2008) · eScholarship@UMassChan · doi:10.13028/1z5s-bb12
“PPARγ has also been implicated in mature adipocyte function [27, 28], as well as triglyceride synthesis and storage [23].”
BackgroundDuarte, F. H. G. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-19092011-152108
Colas, R. A., Lagarde, M., & Calzada, C. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Controversy on high density lipoprotein raising therapy.
Cucuianu, M., & Brudaşcă, I. (2010) · PubMed
Layne, A. S. (2010) · Digital Commons - East Tennessee State University (East Tennessee State University)
Nilsson, A. C. (2007) · Lund University Publications (Lund University)
Genetic Association of the Tenomodulin Gene (TNMD) with
Tolppanen, A. (2009)
On the importance of fat cell size, location and signaling in insulin resistance
Franck, N. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Duration of improved insulin sensitivity after high intensity exercise in young overweight men
Quinn, K. (2015) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-4081
Nutrient regulation of energy metabolism in relation to obesity and type 2 diabetes
Wensaas, A. J. (2010) · NORA - Norwegian Open Research Archives
Koo, S. (2011) · The Korean Journal of Obesity · doi:10.7570/kjo.2011.20.2.45
Study of Factors Regulating Metabolic Syndrome and Insulin Resistance
Nalbandian, M. (2013) · eScholarship (California Digital Library)
Reasner, C. A. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-17
Effects of insulin gene dosage on body weight and glucose homeostasis
Mehran, A. E. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0167270
Mechanisms Mediating Obesity-Induced Inflammation and Insulin Resistance
Schenk, S., Osborn, O., & Olefsky, J. M. (2011) · CRC Press eBooks · doi:10.1201/b11294-14
Insulin as Modulator of Adipose Inflammation
Aljada, A., & Doria, J. W. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch6
Nutrient Interactions and Glucose Homeostasis
Opara, E. C. (2005) · CRC Press eBooks · doi:10.1201/9781420038798.ch10
Insulin resistance in Hispanic male meatpackers
Martine, R. R. (2012) · CU Scholar (University of Colorado Boulder)
Effects of high-fat feeding on skeletal muscle insulin signalling in sarcolipin knockout mice
Sayer, R. A. (2010) · UWSpace (University of Waterloo)
Changes in fatty acids profiles after three weeks of high-fat diet feeding in obesity-prone rats
Liu, T.-W. (2013) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/44001
“Lowering elevated plasma NEFA levels in both lean and obese patients has been shown to improve insulin resistance and glucose tolerance ((12)).”
BackgroundHızel, C., Tremblay, J., Bartlett, G., & Hamet, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809411-2.00001-5
Lifestyle and cardio-metabolic health
Cassidy, S. (2016)
Metadata
- Authors
- Santomauro, A. T., Boden, G., Silva, M. E., Rocha, D. M., Santos, R. F., Ursich, M. J., Strassmann, P. G., & Wajchenberg, B. L.
- Affiliations
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1999-09-01
- Volume
- 48
- Issue
- 9
- Pages
- 1836-1841
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2007405015
- Cited by
- 431
- References
- 0
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 11 · 2020: 20 · 2019: 10 · 2018: 17 · 2017: 18 · 2016: 10 · 2015: 17 · 2014: 18 · 2013: 20 · 2012: 24
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag007988-10, 5r01aa010221-03)
- National Institute on Alcohol Abuse and Alcoholism (R01-AA-10221)
- National Institute on Aging (R01-AG07988)
- National Center for Research Resources (M01RR000349, RR-00349)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- acipimox, free fatty acids, insulin resistance, hyperinsulinemia, glucose tolerance, obesity, type 2 diabetes, impaired glucose tolerance, insulin-stimulated glucose uptake, hyperinsulinemic-euglycemic clamp, oral glucose tolerance test
- MeSH terms
- Adult, Hypolipidemic Agents, Basal Metabolism, Diabetes Mellitus, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Male, Obesity, Oxidation-Reduction, Pyrazines, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
